Effects of Vapiprost, a Novel Thromboxane Receptor Antagonist, on Thrombus Formation and Vascular Patency After Thrombolysis by Tissue-Type Plasminogen Activator

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1992.tb14370.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Thrombolysis of Canine Femoral Artery Thrombus by a Novel Modified Tissue-Type Plasminogen Activator (E6010).

The Japanese Journal of Pharmacology
1994English

Role of Thrombin and Thromboxane A2 in Reocclusion Following Coronary Thrombolysis With Tissue-Type Plasminogen Activator.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Acute Coronary Thrombolysis With Recombinant Human Tissue-Type Plasminogen Activator: Initial Patency and Influence of Maintained Infusion on Reocclusion Rate

American Journal of Cardiology
Cardiovascular MedicineCardiology
1987English

Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation

Circulation
Cardiovascular MedicinePhysiologyCardiology
1991English

Thrombolysis of Subarachnoid Clot Using Tissue Plasminogen Activator

Surgery for Cerebral Stroke
1991English

Coronary Thrombolysis With Facilitated Absorption of Intramuscularly Injected Tissue-Type Plasminogen Activator.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1985English

Effect of Thrombolysis on Myocardial Injury: Recombinant Tissue Plasminogen Activator vs. Alfimeprase

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2006English

Novel Actions of Tissue-Type Plasminogen Activator in Chronic Kidney Disease

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.

Journal of Pharmacobio-Dynamics
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy